Alto Neuroscience Funding & Investors
Los Altos, CA
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
altoneuroscience.comTotal Amount Raised: $300,961,344
Alto Neuroscience Funding Rounds
Post Ipo Equity
$49,999,533
Post Ipo Equity Investors
Perceptive AdvisorsCommodore CapitalVivo CapitalVestal Point CapitalGrant
$11,700,000
Grant Investors
Wellcome TrustIPO
Unknown
Series Unknown
$59,261,815
Series C
$45,000,000
Series C Investors
InVivium CapitalLightswitch CapitalWindham Venture PartnersEli Lilly and CompanyFranklin Resources, Inc.What If VenturesAlkeon CapitalAlexandria Real Estate EquitiesPoint72 VenturesAlpha Wave GlobalSeries B
$25,000,000
Series B Investors
Alpha Wave GlobalCatalytic Impact FoundationDebt Financing
$35,000,000
Debt Financing Investors
K2 HealthVenturesSeries B
$35,000,000
Series B Investors
Alkeon CapitalLightswitch CapitalWhat If VenturesSobrato CapitalApeiron Investment GroupVine VenturesWindham Venture PartnersNovartis PharmaKorify CapitalGaingelsValor Equity PartnersPresight Capitalinfinitas capitalSeries A
$32,000,000
Series A Investors
Apeiron Investment GroupPresight CapitalLeland Stanford Junior UniversityRisk and ReturnWhat If VenturesAble PartnersWindham Venture PartnersTim KendallKorify CapitalPsyMed VenturesSeed
$8,000,000
Seed Investors
Tim Kendall
Funding info provided by Diffbot.